There are disclosed hybrid proteins consisting of mutated sequences of Par j 1 and Par j 2 allergens linked to each other either directly or by interposition of a linker, nucleic acid molecules encoding for them, pharmaceutical compositions containing the same, and their use in the immunotherapy of allergic diseases caused by pollen of plants from Parietaria judaica species.
